Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caelyx in Advanced Gastric Cancer
NCT00004236Phase 2Unknown
- Sponsor
- University of Leicester
- Start
- Aug 1998
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin in gastric cancer (GC), sponsored by University of Leicester. Status: unknown.
02
Drugs
pegylated liposomal doxorubicin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00004236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004236.